Meningococcal Group B Vaccine and Forecast - Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Meningococcal Group B Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Group B Vaccine Segment by Type
1.2.2 Meningococcal Group B Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Meningococcal Group B Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Meningococcal Group B Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Meningococcal Group B Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Meningococcal Group B Vaccine Market Competitive Landscape
3.1 Global Meningococcal Group B Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Meningococcal Group B Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Group B Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Group B Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Meningococcal Group B Vaccine Industry Chain Analysis
4.1 Meningococcal Group B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Meningococcal Group B Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Meningococcal Group B Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Group B Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Meningococcal Group B Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Meningococcal Group B Vaccine Price by Type (2019-2025)
7 Meningococcal Group B Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Group B Vaccine Market Sales by Application (2019-2025)
7.3 Global Meningococcal Group B Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2025)
8 Meningococcal Group B Vaccine Market Consumption by Region
8.1 Global Meningococcal Group B Vaccine Sales by Region
8.1.1 Global Meningococcal Group B Vaccine Sales by Region
8.1.2 Global Meningococcal Group B Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Group B Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Group B Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Group B Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Meningococcal Group B Vaccine Market Production by Region
9.1 Global Production of Meningococcal Group B Vaccine by Region (2019-2025)
9.2 Global Meningococcal Group B Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Meningococcal Group B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Meningococcal Group B Vaccine Production
9.4.1 North America Meningococcal Group B Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Meningococcal Group B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Meningococcal Group B Vaccine Production
9.5.1 Europe Meningococcal Group B Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Meningococcal Group B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Meningococcal Group B Vaccine Production (2019-2025)
9.6.1 Japan Meningococcal Group B Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Meningococcal Group B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Meningococcal Group B Vaccine Production (2019-2025)
9.7.1 China Meningococcal Group B Vaccine Production Growth Rate (2019-2025)
9.7.2 China Meningococcal Group B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GSK
10.1.1 GSK Meningococcal Group B Vaccine Basic Information
10.1.2 GSK Meningococcal Group B Vaccine Product Overview
10.1.3 GSK Meningococcal Group B Vaccine Product Market Performance
10.1.4 GSK Business Overview
10.1.5 GSK Meningococcal Group B Vaccine SWOT Analysis
10.1.6 GSK Recent Developments
10.2 Pfizer
10.2.1 Pfizer Meningococcal Group B Vaccine Basic Information
10.2.2 Pfizer Meningococcal Group B Vaccine Product Overview
10.2.3 Pfizer Meningococcal Group B Vaccine Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer Meningococcal Group B Vaccine SWOT Analysis
10.2.6 Pfizer Recent Developments
11 Meningococcal Group B Vaccine Market Forecast by Region
11.1 Global Meningococcal Group B Vaccine Market Size Forecast
11.2 Global Meningococcal Group B Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Group B Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Group B Vaccine Market Size Forecast by Region
11.2.4 South America Meningococcal Group B Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Group B Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Meningococcal Group B Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2025-2032)
12.1.2 Global Meningococcal Group B Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Meningococcal Group B Vaccine by Type (2025-2032)
12.2 Global Meningococcal Group B Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Meningococcal Group B Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Meningococcal Group B Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Group B Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Group B Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Meningococcal Group B Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2022)
Table 10. Global Market Meningococcal Group B Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Meningococcal Group B Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Group B Vaccine Product Type
Table 13. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Group B Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Group B Vaccine Market Challenges
Table 22. Global Meningococcal Group B Vaccine Sales by Type (K MT)
Table 23. Global Meningococcal Group B Vaccine Market Size by Type (M USD)
Table 24. Global Meningococcal Group B Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Meningococcal Group B Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Meningococcal Group B Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Meningococcal Group B Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Meningococcal Group B Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Meningococcal Group B Vaccine Sales (K MT) by Application
Table 30. Global Meningococcal Group B Vaccine Market Size by Application
Table 31. Global Meningococcal Group B Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Meningococcal Group B Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Meningococcal Group B Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Meningococcal Group B Vaccine Market Share by Application (2019-2025)
Table 35. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Meningococcal Group B Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Meningococcal Group B Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Meningococcal Group B Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Meningococcal Group B Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Meningococcal Group B Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Meningococcal Group B Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Meningococcal Group B Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Meningococcal Group B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Meningococcal Group B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Meningococcal Group B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Meningococcal Group B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Meningococcal Group B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. GSK Meningococcal Group B Vaccine Basic Information
Table 52. GSK Meningococcal Group B Vaccine Product Overview
Table 53. GSK Meningococcal Group B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. GSK Business Overview
Table 55. GSK Meningococcal Group B Vaccine SWOT Analysis
Table 56. GSK Recent Developments
Table 57. Pfizer Meningococcal Group B Vaccine Basic Information
Table 58. Pfizer Meningococcal Group B Vaccine Product Overview
Table 59. Pfizer Meningococcal Group B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Pfizer Business Overview
Table 61. Pfizer Meningococcal Group B Vaccine SWOT Analysis
Table 62. Pfizer Recent Developments
Table 63. Global Meningococcal Group B Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 64. Global Meningococcal Group B Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 65. North America Meningococcal Group B Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 66. North America Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 67. Europe Meningococcal Group B Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 68. Europe Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 69. Asia Pacific Meningococcal Group B Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 70. Asia Pacific Meningococcal Group B Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 71. South America Meningococcal Group B Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 72. South America Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 73. Middle East and Africa Meningococcal Group B Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 74. Middle East and Africa Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 75. Global Meningococcal Group B Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 76. Global Meningococcal Group B Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 77. Global Meningococcal Group B Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 78. Global Meningococcal Group B Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 79. Global Meningococcal Group B Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Meningococcal Group B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Group B Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Meningococcal Group B Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Meningococcal Group B Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Group B Vaccine Market Size by Country (M USD)
Figure 11. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningococcal Group B Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Group B Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Group B Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningococcal Group B Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Meningococcal Group B Vaccine by Type in 2023
Figure 20. Market Size Share of Meningococcal Group B Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Meningococcal Group B Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Group B Vaccine Market Share by Application
Figure 24. Global Meningococcal Group B Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningococcal Group B Vaccine Market Share by Application (2019-2025)
Figure 27. Global Meningococcal Group B Vaccine Market Share by Application in 2023
Figure 28. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Meningococcal Group B Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Meningococcal Group B Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Meningococcal Group B Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Meningococcal Group B Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Meningococcal Group B Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Meningococcal Group B Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Meningococcal Group B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Meningococcal Group B Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Meningococcal Group B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Meningococcal Group B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Meningococcal Group B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Meningococcal Group B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Meningococcal Group B Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Meningococcal Group B Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Meningococcal Group B Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Meningococcal Group B Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Meningococcal Group B Vaccine Market Share Forecast by Application (2025-2032)